Platelet-rich plasma (PRP) · Lesson 12 of 25 · 3 min

PRP for osteoarthritis beyond the knee: hip, shoulder, ankle and hand

PRP evidence in osteoarthritis is joint-specific. Knee data are strongest, hip and shoulder results resemble hyaluronic acid, and a key ankle trial found no benefit over saline.

Gloved hands placing a sample tube into a centrifuge

Key takeaways.

  • Findings from knee osteoarthritis do not automatically apply to other joints.
  • Reviews report the most benefit in early to moderate disease, Kellgren-Lawrence grades I to III.
  • In hip osteoarthritis, studies report outcomes similar to hyaluronic acid.
  • A shoulder trial found improvement with both PRP and hyaluronic acid, with minimal difference between them.
  • A placebo-controlled ankle trial found no significant benefit of PRP over saline.
  • Thumb base osteoarthritis shows more promising results, from a smaller evidence base.

How PRP is thought to act in a joint

Osteoarthritis affects cartilage, the synovium (joint lining), the bone under the cartilage and nearby tissue. Platelet-rich plasma (PRP) contains growth factors such as TGF-beta that signal to chondrocytes (cartilage cells) and synovial cells.

The proposed effects are on cartilage maintenance and on inflammation inside the joint. These mechanisms are the same in every joint. Clinical results are not.

Disease stage matters

The Kellgren-Lawrence (KL) scale is the most widely used X-ray grading of osteoarthritis. It runs from grade 0, a normal joint, to grade IV, advanced disease.

Systematic reviews consistently report that PRP studies show the most benefit in grades I to III, with diminishing returns in grade IV.

Evidence joint by joint

Knee osteoarthritis has the largest evidence base. In the hip, studies report improvement from baseline, but many lacked control groups, and comparative data show outcomes similar to hyaluronic acid. In the shoulder (glenohumeral joint), a 2022 randomized trial of 70 people found that PRP and hyaluronic acid performed about equally.

The ankle is the cautionary case. A 2023 double-blind, placebo-controlled trial found no significant benefit of PRP over saline injection. In the thumb carpometacarpal joint, early results are more promising, though the research is limited.

Combining PRP with hyaluronic acid is also under study, based on the idea that the two act through different pathways.

Delivery and regulatory status

Injection accuracy varies by joint. Deep joints such as the hip, shoulder and ankle are usually injected under ultrasound or fluoroscopy guidance.

PRP applications are considered off-label. Informed consent should reflect the evidence for the specific joint being treated.

Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.

Platelet-rich plasma (PRP): 0 of 25 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Reading radiographs and grading osteoarthritis for patient selection
  • Ultrasound and fluoroscopy guidance for deep joints
  • Joint-specific preparation and injection protocols
  • PRP and hyaluronic acid combination approaches
  • Outcome measures and follow-up planning

Common questions.

Does PRP help ankle osteoarthritis?
A 2023 double-blind, placebo-controlled randomized trial found no significant benefit of PRP over saline for ankle (talocrural) osteoarthritis.
Is PRP better than hyaluronic acid for hip or shoulder osteoarthritis?
Current studies do not show clear superiority. Hip outcomes are reported as comparable to hyaluronic acid, and a shoulder trial found minimal difference between the two.
Which osteoarthritis grades are studied most with PRP?
Most supportive data come from early to moderate disease, Kellgren-Lawrence grades I to III. Reviews report diminishing benefit in grade IV.

Sources

  • Paget LDA, et al. (2023). Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in individuals with ankle osteoarthritis: a randomized clinical trial. JAMA, 330(16):1648-1657.
  • Sánchez M, et al. (2022). Efficacy of ultrasound-guided glenohumeral joint injections of leukocyte-poor platelet-rich plasma versus hyaluronic acid in the treatment of glenohumeral osteoarthritis: a randomized, double-blind controlled trial. J Shoulder Elbow Surg, 31(11):2367-2378.
  • Andia I, Maffulli N. (2013). Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol, 9(12):721-730.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.